InvestorsHub Logo
Followers 6
Posts 2155
Boards Moderated 0
Alias Born 11/26/2014

Re: None

Monday, 02/19/2018 11:49:19 AM

Monday, February 19, 2018 11:49:19 AM

Post# of 38634
I have done some looking into the Chinese deal. I think I have good idea what is going on. The latest info only gives a few lines, but I think it tells all. Here are my opinions:

1. Smart Pharma will have no involvement with IPCI. It appears they may be in the market of creating/ selling drugs for specific ailments/conditions in Africa. These types of products have nothing to do with IPCI's core business of controlled release drugs. Dr. Odidi may or may not have some involvement with this company. But it does not matter as they are not a competitor to IPCI.
2. Partnerships. I believe IPCI is looking for various manufacturing and possibly marketing partners in China. I believe an Obvious one is Shanghai Yunfeng Pharmaceuticals. I believe this company would be a good fit to manufacture Gluco and Keppra at the pricepoint it need to be manufactured to compete. Could be other companies they are looking into, but this is one they obviously have ties to, so you figure it out...
3. Contract manufacturing. Same as number 2. They are looking for someone to manufacture generics at low cost for all markets. I believe this is Shanghai Yunfeng.
4. Raw Materials Sourcing. IPCI has also been looking for lower cost sources for raw materials in China. I believe first intent is to get these materials shipped to Toronto. So that they can produce, Seroquel, etc. for lower costs. I am guessing this source for raw materials is Shanghai Yunfeng source. But don't be surprised if when they partner with Shanghai Yunfeng that Seroquel production also moves to China. One again at Shanghai Yunfeng Pharmaceuticals.

That pretty much sums up my opinions...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y